C100H89BrCl3N31O6 — CID 172934243
3-bromo-6-chloroimidazo[1,2-b]pyridazine;(6-chloroimidazo[1,2-b]pyridazin-3-yl)-(1-methylindazol-5-yl)methanol;6-chloro-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;6-(1-ethoxyethenyl)-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;1-methylindazole-5-carbaldehyde;1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethanone;2-[(E)-1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethylideneamino]oxyethanol (PubChem CID 172934243) has the molecular formula C100H89BrCl3N31O6 and a molecular weight of 2007.29 g/mol. Its IUPAC name is 3-bromo-6-chloroimidazo[1,2-b]pyridazine;(6-chloroimidazo[1,2-b]pyridazin-3-yl)-(1-methylindazol-5-yl)methanol;6-chloro-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;6-(1-ethoxyethenyl)-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;1-methylindazole-5-carbaldehyde;1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethanone;2-[(E)-1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethylideneamino]oxyethanol.
| Compound Name | 3-bromo-6-chloroimidazo[1,2-b]pyridazine;(6-chloroimidazo[1,2-b]pyridazin-3-yl)-(1-methylindazol-5-yl)methanol;6-chloro-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;6-(1-ethoxyethenyl)-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;1-methylindazole-5-carbaldehyde;1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethanone;2-[(E)-1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethylideneamino]oxyethanol |
|---|---|
| PubChem CID | 172934243 |
| Molecular Formula | C100H89BrCl3N31O6 |
| Molecular Weight | 2007.29 g/mol |
| Exact Mass | 2003.59 |
| IUPAC Name | 3-bromo-6-chloroimidazo[1,2-b]pyridazine;(6-chloroimidazo[1,2-b]pyridazin-3-yl)-(1-methylindazol-5-yl)methanol;6-chloro-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;6-(1-ethoxyethenyl)-3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazine;1-methylindazole-5-carbaldehyde;1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethanone;2-[(E)-1-[3-[(1-methylindazol-5-yl)methyl]imidazo[1,2-b]pyridazin-6-yl]ethylideneamino]oxyethanol |
| SMILES | C/C(=N\OCCO)c1ccc2ncc(Cc3ccc4c(cnn4C)c3)n2n1.C=C(OCC)c1ccc2ncc(Cc3ccc4c(cnn4C)c3)n2n1.CC(=O)c1ccc2ncc(Cc3ccc4c(cnn4C)c3)n2n1.Clc1ccc2ncc(Br)n2n1.Cn1ncc2cc(C(O)c3cnc4ccc(Cl)nn34)ccc21.Cn1ncc2cc(C=O)ccc21.Cn1ncc2cc(Cc3cnc4ccc(Cl)nn34)ccc21 |
| InChI | InChI=1S/C19H20N6O2.C19H19N5O.C17H15N5O.C15H12ClN5O.C15H12ClN5.C9H8N2O.C6H3BrClN3/c1-13(23-27-8-7-26)17-4-6-19-20-12-16(25(19)22-17)10-14-3-5-18-15(9-14)11-21-24(18)2;1-4-25-13(2)17-6-8-19-20-12-16(24(19)22-17)10-14-5-7-18-15(9-14)11-21-23(18)3;1-11(23)15-4-6-17-18-10-14(22(17)20-15)8-12-3-5-16-13(7-12)9-19-21(16)2;1-20-11-3-2-9(6-10(11)7-18-20)15(22)12-8-17-14-5-4-13(16)19-21(12)14;1-20-13-3-2-10(6-11(13)8-18-20)7-12-9-17-15-5-4-14(16)19-21(12)15;1-11-9-3-2-7(6-12)4-8(9)5-10-11;7-4-3-9-6-2-1-5(8)10-11(4)6/h3-6,9,11-12,26H,7-8,10H2,1-2H3;5-9,11-12H,2,4,10H2,1,3H3;3-7,9-10H,8H2,1-2H3;2-8,15,22H,1H3;2-6,8-9H,7H2,1H3;2-6H,1H3;1-3H/b23-13+;;;;;; |
| InChIKey | FBGYVEAXVCRZQV-UTEIFINGSA-N |
| XLogP | 16.31 |
| TPSA | 393.48 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 141 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2007.29 |
| LogP ≤ 5 | 16.31 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 37 |
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|